Total Funding
56
86
Total FundingSeed raised
Growth Score 56 in past quarter
-5 pts
Heat Score 86 in past quarter
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
37629
Qum Therapeutics Develops immunotherapies that target pathogenic cells and engage the patient’s immune system to control disease.
About the Company
Qum Therapeutics Develops immunotherapies that target pathogenic cells. The company designs treatments to engage the patient’s immune system and control disease progression. Its approach focuses on precision targeting and minimizing side effects. The technology is applied to cancer and other diseases that involve pathogenic cells.
